First Time Loading...

RVL Pharmaceuticals PLC
NASDAQ:RVLP

Watchlist Manager
RVL Pharmaceuticals PLC Logo
RVL Pharmaceuticals PLC
NASDAQ:RVLP
Watchlist
Price: 0.0024 USD 14.29%
Updated: May 7, 2024

Income Statement

Earnings Waterfall
RVL Pharmaceuticals PLC

Revenue
36.9m USD
Cost of Revenue
-9.3m USD
Gross Profit
27.6m USD
Operating Expenses
-70.2m USD
Operating Income
-42.6m USD
Other Expenses
-25.7m USD
Net Income
-68.3m USD

Income Statement
RVL Pharmaceuticals PLC

Rotate your device to view
Income Statement
Currency: USD
Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023
Revenue
Revenue
74
N/A
50
-32%
18
-63%
39
+111%
35
-10%
43
+22%
50
+16%
37
-25%
37
-1%
Gross Profit
Cost of Revenue
(20)
(20)
(4)
(6)
(7)
(8)
(9)
(10)
(9)
Gross Profit
53
N/A
30
-44%
14
-52%
33
+135%
28
-15%
35
+23%
40
+16%
27
-32%
28
+0%
Operating Income
Operating Expenses
(110)
(113)
(112)
(118)
(95)
(89)
(83)
(91)
(70)
Selling, General & Administrative
(97)
(100)
(103)
(110)
(91)
(85)
(79)
(71)
(67)
Research & Development
(8)
(8)
(9)
(8)
(5)
(4)
(4)
(4)
(3)
Other Operating Expenses
(5)
(5)
0
0
0
0
0
(16)
0
Operating Income
(57)
N/A
(83)
-47%
(98)
-18%
(85)
+14%
(67)
+21%
(55)
+18%
(43)
+22%
(64)
-49%
(43)
+33%
Pre-Tax Income
Interest Income Expense
(6)
(5)
(5)
(6)
(5)
(1)
(0)
(6)
(9)
Non-Reccuring Items
(46)
(46)
3
(2)
(2)
(3)
(16)
0
(28)
Total Other Income
(1)
(1)
4
5
9
5
8
13
11
Pre-Tax Income
(109)
N/A
(135)
-24%
(95)
+29%
(88)
+7%
(65)
+27%
(53)
+18%
(52)
+2%
(56)
-9%
(69)
-22%
Net Income
Tax Provision
6
4
(0)
(0)
(0)
(0)
0
(0)
0
Income from Continuing Operations
(103)
(131)
(96)
(89)
(65)
(53)
(52)
(56)
(68)
Net Income (Common)
(100)
N/A
(110)
-9%
(75)
+32%
(72)
+4%
(57)
+21%
(53)
+6%
(52)
+3%
(56)
-9%
(68)
-21%
EPS (Diluted)
-1.6
N/A
-1.74
-9%
-0.91
+48%
-0.85
+7%
-0.67
+21%
-0.57
+15%
-0.52
+9%
-0.56
-8%
-0.7
-25%

See Also

Discover More